CONTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.533
EU - Europa 4.651
AS - Asia 2.457
SA - Sud America 323
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 2
Totale 13.003
Nazione #
US - Stati Uniti d'America 5.511
IE - Irlanda 1.516
HK - Hong Kong 861
UA - Ucraina 847
SG - Singapore 828
GB - Regno Unito 673
CN - Cina 442
IT - Italia 430
DE - Germania 412
BR - Brasile 294
SE - Svezia 254
FI - Finlandia 213
TR - Turchia 188
GR - Grecia 110
KR - Corea 56
RU - Federazione Russa 42
BE - Belgio 39
FR - Francia 38
CZ - Repubblica Ceca 23
AT - Austria 20
IR - Iran 13
CA - Canada 12
NL - Olanda 11
AR - Argentina 8
IQ - Iraq 8
MA - Marocco 8
UZ - Uzbekistan 7
EU - Europa 6
ID - Indonesia 6
IN - India 6
JP - Giappone 6
PK - Pakistan 6
BD - Bangladesh 5
ES - Italia 5
SC - Seychelles 5
CL - Cile 4
EC - Ecuador 4
MX - Messico 4
TN - Tunisia 4
VE - Venezuela 4
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
HU - Ungheria 3
KE - Kenya 3
MY - Malesia 3
PT - Portogallo 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MN - Mongolia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
ZA - Sudafrica 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
NP - Nepal 1
PH - Filippine 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 13.003
Città #
Dublin 1.515
Jacksonville 1.280
Chandler 924
Hong Kong 860
Santa Clara 860
Princeton 236
Medford 219
Singapore 204
Ann Arbor 158
Boardman 155
San Mateo 145
Roxbury 127
Wilmington 96
Beijing 94
Woodbridge 93
New York 66
Bremen 58
Nanjing 55
Seoul 49
Jinan 48
Caserta 47
Brussels 38
The Dalles 36
Des Moines 34
Saint Petersburg 32
Norwalk 28
Istanbul 27
Cambridge 26
Mountain View 26
Shenyang 26
Munich 25
Houston 23
Brno 22
São Paulo 22
Zhengzhou 20
Ashburn 19
Naples 19
Belo Horizonte 18
Milan 17
Napoli 17
Guangzhou 13
Hangzhou 13
Los Angeles 13
Ningbo 13
Rome 13
Taiyuan 12
Taizhou 12
Bologna 11
Helsinki 11
Auburn Hills 10
Düsseldorf 10
Nanchang 9
Nuremberg 9
Redwood City 9
Shanghai 9
Tianjin 9
Vienna 9
Zanjan 9
Jiaxing 8
Rio de Janeiro 8
Seattle 8
Changsha 7
Turin 7
Curitiba 6
Florence 6
Kunming 6
Ottawa 6
Tashkent 6
Groningen 5
Haikou 5
Palermo 5
Sorocaba 5
Cantù 4
Erbil 4
Fairfield 4
Falkenstein 4
Genova 4
Hanover 4
Hebei 4
Juiz de Fora 4
Lanzhou 4
Ribeirão Preto 4
Torino 4
Campinas 3
Casablanca 3
Cattolica 3
Chicago 3
Dallas 3
Dearborn 3
Ercolano 3
Jacareí 3
Modena 3
Nairobi 3
North Bergen 3
Padova 3
Potenza 3
Recife 3
Sacramento 3
Santiago 3
Santo André 3
Totale 8.141
Nome #
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 143
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 129
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 124
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 104
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 103
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 88
A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in chronic renal insufficiency (UBI) Study. J Nephrol 2011 Aug 23.0. doi: 10.5301/jn.5000014. Epub ahead of print 86
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 86
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 82
Amino acid loss during dialysis treatment 82
[Anti-diabetics and chronic kidney disease] 82
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 81
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 81
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 80
Daily nutrient intake in hemodialysis. 79
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 79
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 78
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 78
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 77
Epidemiology of chronic kidney disease in Italy: the CARHES study 75
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 74
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 74
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 74
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 73
[Iron deficiency in ND-CKD: from diagnosis to treatment] 72
Reversibility of acute cyclosporine renal impairment by dopamine in healthy subjects 71
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 70
Management of hypertension in chronic kidney disease: the Italian multicenter study. 70
Acute renal and immunological effects of low-dose cyclosporin in humans 70
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 70
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 70
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 69
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 69
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 69
Acute cyclosporine A nephrotoxicity 69
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 68
Management of hypertension in chronic kidney disease 68
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 68
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 67
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 67
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 67
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 66
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 66
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 66
Epidemiology of CKD Regression in Patients under Nephrology Care 66
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 65
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 65
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 65
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 65
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 64
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 64
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 64
Disfunzione renale nell’anziano: processo fisiologico o malattia? 64
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 64
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 63
Dopamine counteracts the acute renal effects of cyclosporine in normal subjects 63
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 63
Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up 63
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 63
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 63
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 63
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 62
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 62
Effects of a two-month treatment with low oral doses of cyclosporin on renal function 62
Heart Failure in chronic kidney disease: from epidemiology to therapy. 62
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 62
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 62
Acute renal failure of unknown origin. Don't forget renal tuberculosis 62
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 62
A new diuretic: the Atrial Natriuretic Peptide 62
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 62
[Epidemiology and prognosis of chronic kidney disease in Italy] 62
Epidemiology of chronic kidney disease in Italy 61
Assessment of Nutritional Practice in Italian Chronic Kidney Disease Clinics: A Questionnaire-Based Survey 61
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 61
Role of atrial natriuretic factor in renal adaptation to variation of salt intake in humans 60
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis 60
Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial 60
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 60
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 60
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 59
Epoetin therapy and hemoglobin level variability in non-dialysis CKD patients 59
Stability of target hemoglobin levels during the first year of epoetin treatment in CKD patients. 59
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 59
Competing-Risk Analysis of Death and End Stage Kidney Disease by Hyperkalaemia Status in Non-Dialysis Chronic Kidney Disease Patients Receiving Stable Nephrology Care 59
Gestione dei fattori di rischio cardiovascolare (CV) nella nefropatia diabetica tipo 2 (ND): analisi comparativa tra nefrologia, diabetologia e medicina generale 59
Manuale di Terapia delle Malattie Renali 59
Resistant hypertension in nondialysis chronic kidney disease. 59
Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney disease 58
Assessment of Nutritional Practice in Italian Chronic Kidney Disease Clinics: A Questionnaire-Based Survey. J Ren Nutr 2010;20:82-90 58
Acute effects of low-dose cyclosporine on renal function in normal subjects 58
Effetti della infusione di dopamina sulla nefrotossicità acuta indotta dalla ciclosporina A 58
Prevention of diabetic nephropathy: from bench to bedside 58
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 58
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 58
Salt intake and renal outcome in patients with progressive renal disease 57
Daily nutrient intake represents a modifiable determinant of nutritional status in chronic haemodialysis patients 57
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes 56
Hypertension in patients on hemodialysis: the role of salt intake. 56
Medium-term cyclosporin renal dysfunction and its reversibility in rats 56
Totale 6.896
Categoria #
all - tutte 59.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 0 0 0 0 0 0 55 10
2020/20211.896 182 13 230 152 370 8 240 205 14 260 165 57
2021/20221.449 160 1 7 22 517 12 17 32 57 115 122 387
2022/20233.053 247 50 37 314 324 289 8 183 1.453 26 60 62
2023/20241.092 100 39 50 116 397 71 12 25 8 20 83 171
2024/20253.057 7 67 61 93 511 499 514 304 373 607 21 0
Totale 13.301